Paraneoplastic hemolytic anemia associated with prostate cancer. A case report
Open Access
- 18 November 2022
- journal article
- research article
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 45 (3)
Abstract
Los síndromes paraneoplásicos son un conjunto de síntomas asociados a los tumores, no atribuibles al efecto directo del tumor o de sus metástasis. Estos síntomas pueden ser secundarios a sustancias secretadas por el tumor, o a la producción de anticuerpos contra tejido tumoral que presenta reacción cruzada con tejidos normales. Dentro de los síndromes paraneoplásicos hematológicos, las anemias hemolíticas son poco frecuentes, especialmente en tumores sólidos.Keywords
This publication has 10 references indexed in Scilit:
- How I treat microangiopathic hemolytic anemia in patients with cancerBlood, 2021
- New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic AnemiaFrontiers in Immunology, 2020
- Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatmentBlood Advances, 2019
- Low-dose rituximab in autoimmune hemolytic anemia: 10 years afterBlood, 2019
- Diagnostic approach to microangiopathic hemolytic disordersInternational Journal of Laboratory Hematology, 2017
- Unusual co-occurrence of Evans syndrome and pure red cell aplasia in elderly patient with prostate cancerAnnals of Hematology, 2016
- Cancer-Related Microangiopathic Hemolytic AnemiaMedicine, 2012
- Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: A critical analysis of 52 cases reported in the literatureWiener klinische Wochenschrift, 2010
- The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patientsEuropean Journal of Cancer, 2004
- Anemia and CancerCA: A Cancer Journal for Clinicians, 1989